In the future exploration of the treatment of depression by CYWD, it may be possible to extract the active ingredients according to the results of HPLC-MS analysis, and conduct an in-depth exploration of the upstream and downstream mechanisms by which CYWD prevents the apoptosis of hippocampal neurons through the AKT/CREB signaling pathway. The gene discussed is AKT1; the disease is depressive symptom measurement.